# Multiple Ascending Doses (MAD) of AZD3199 Given Once Daily as Inhaled Formulation Via Turbuhaler to Healthy Men

> **NCT00713271** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 27 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** AZD3199
- **DRUG:** Placebo
- **DRUG:** AZD3199
- **DRUG:** AZD3199

## Key facts

- **NCT ID:** NCT00713271
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2014-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00713271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00713271, "Multiple Ascending Doses (MAD) of AZD3199 Given Once Daily as Inhaled Formulation Via Turbuhaler to Healthy Men". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00713271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*